vs
Side-by-side financial comparison of Astrana Health, Inc. (ASTH) and MARRIOTT VACATIONS WORLDWIDE Corp (VAC). Click either name above to swap in a different company.
MARRIOTT VACATIONS WORLDWIDE Corp is the larger business by last-quarter revenue ($1.2B vs $950.5M, roughly 1.3× Astrana Health, Inc.). Astrana Health, Inc. runs the higher net margin — 0.7% vs -35.0%, a 35.7% gap on every dollar of revenue. On growth, Astrana Health, Inc. posted the faster year-over-year revenue change (42.9% vs -0.7%). Astrana Health, Inc. produced more free cash flow last quarter ($-6.0M vs $-6.0M). Over the past eight quarters, Astrana Health, Inc.'s revenue compounded faster (53.3% CAGR vs 5.2%).
Astrana Health, Inc. is a U.S.-based value-based healthcare services provider that primarily serves Medicare-eligible senior populations across the United States. It offers in-home primary care, chronic disease management, and care coordination services, aiming to improve patient health outcomes and reduce unnecessary medical costs.
Marriott Vacations Worldwide Corporation is a pure-play public timeshare company. Formerly a division of Marriott International, Marriott Vacations Worldwide was established as a separate, publicly traded entity focusing primarily on vacation ownership in November 2011. Marriott Vacations Worldwide runs more than 120 resorts with over 700,000 Owners and members in a diverse portfolio of brands under The Marriott Vacation Clubs name. Its brands include Marriott Vacation Club, The Marriott Vaca...
ASTH vs VAC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $950.5M | $1.2B |
| Net Profit | $6.6M | $-431.0M |
| Gross Margin | — | — |
| Operating Margin | 1.9% | — |
| Net Margin | 0.7% | -35.0% |
| Revenue YoY | 42.9% | -0.7% |
| Net Profit YoY | 184.4% | -962.0% |
| EPS (diluted) | $0.12 | $-12.00 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $950.5M | $1.2B | ||
| Q3 25 | $956.0M | $1.2B | ||
| Q2 25 | $654.8M | $1.2B | ||
| Q1 25 | $620.4M | $1.1B | ||
| Q4 24 | $665.2M | $1.2B | ||
| Q3 24 | $478.7M | $1.2B | ||
| Q2 24 | $486.3M | $1.1B | ||
| Q1 24 | $404.4M | $1.1B |
| Q4 25 | $6.6M | $-431.0M | ||
| Q3 25 | $373.0K | $-2.0M | ||
| Q2 25 | $9.4M | $69.0M | ||
| Q1 25 | $6.7M | $56.0M | ||
| Q4 24 | $-7.8M | $50.0M | ||
| Q3 24 | $16.1M | $84.0M | ||
| Q2 24 | $19.2M | $37.0M | ||
| Q1 24 | $14.8M | $47.0M |
| Q4 25 | 1.9% | — | ||
| Q3 25 | 2.0% | — | ||
| Q2 25 | 3.1% | — | ||
| Q1 25 | 3.3% | — | ||
| Q4 24 | 0.1% | — | ||
| Q3 24 | 5.9% | — | ||
| Q2 24 | 6.2% | — | ||
| Q1 24 | 7.5% | — |
| Q4 25 | 0.7% | -35.0% | ||
| Q3 25 | 0.0% | -0.2% | ||
| Q2 25 | 1.4% | 6.0% | ||
| Q1 25 | 1.1% | 5.0% | ||
| Q4 24 | -1.2% | 4.0% | ||
| Q3 24 | 3.4% | 6.9% | ||
| Q2 24 | 3.9% | 3.5% | ||
| Q1 24 | 3.7% | 4.2% |
| Q4 25 | $0.12 | $-12.00 | ||
| Q3 25 | $0.01 | $-0.07 | ||
| Q2 25 | $0.19 | $1.77 | ||
| Q1 25 | $0.14 | $1.46 | ||
| Q4 24 | $-0.14 | $1.29 | ||
| Q3 24 | $0.33 | $2.12 | ||
| Q2 24 | $0.40 | $0.98 | ||
| Q1 24 | $0.31 | $1.22 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $429.5M | $406.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $779.3M | $2.0B |
| Total Assets | $2.2B | $9.8B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $429.5M | $406.0M | ||
| Q3 25 | $463.4M | $474.0M | ||
| Q2 25 | $342.1M | $205.0M | ||
| Q1 25 | $260.9M | $196.0M | ||
| Q4 24 | $290.8M | $197.0M | ||
| Q3 24 | $350.3M | $197.0M | ||
| Q2 24 | $327.7M | $206.0M | ||
| Q1 24 | $337.3M | $237.0M |
| Q4 25 | $779.3M | $2.0B | ||
| Q3 25 | $775.5M | $2.5B | ||
| Q2 25 | $765.5M | $2.5B | ||
| Q1 25 | $745.4M | $2.4B | ||
| Q4 24 | $712.7M | $2.4B | ||
| Q3 24 | $704.6M | $2.4B | ||
| Q2 24 | $678.9M | $2.4B | ||
| Q1 24 | $653.5M | $2.4B |
| Q4 25 | $2.2B | $9.8B | ||
| Q3 25 | $2.2B | $10.1B | ||
| Q2 25 | $1.4B | $9.9B | ||
| Q1 25 | $1.3B | $9.9B | ||
| Q4 24 | $1.4B | $9.8B | ||
| Q3 24 | $1.3B | $9.7B | ||
| Q2 24 | $1.3B | $9.6B | ||
| Q1 24 | $1.2B | $9.9B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.9M | $6.0M |
| Free Cash FlowOCF − Capex | $-6.0M | $-6.0M |
| FCF MarginFCF / Revenue | -0.6% | -0.5% |
| Capex IntensityCapex / Revenue | 0.3% | 1.0% |
| Cash ConversionOCF / Net Profit | -0.44× | — |
| TTM Free Cash FlowTrailing 4 quarters | $104.5M | $-29.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.9M | $6.0M | ||
| Q3 25 | $10.0M | $62.0M | ||
| Q2 25 | $90.9M | $-48.0M | ||
| Q1 25 | $16.6M | $8.0M | ||
| Q4 24 | $-10.9M | $100.0M | ||
| Q3 24 | $34.0M | $72.0M | ||
| Q2 24 | $23.2M | $30.0M | ||
| Q1 24 | $6.0M | $3.0M |
| Q4 25 | $-6.0M | $-6.0M | ||
| Q3 25 | $7.4M | $51.0M | ||
| Q2 25 | $89.5M | $-68.0M | ||
| Q1 25 | $13.6M | $-6.0M | ||
| Q4 24 | $-13.5M | $86.0M | ||
| Q3 24 | $31.7M | $58.0M | ||
| Q2 24 | $20.4M | $17.0M | ||
| Q1 24 | $5.6M | $-13.0M |
| Q4 25 | -0.6% | -0.5% | ||
| Q3 25 | 0.8% | 4.3% | ||
| Q2 25 | 13.7% | -5.9% | ||
| Q1 25 | 2.2% | -0.5% | ||
| Q4 24 | -2.0% | 6.9% | ||
| Q3 24 | 6.6% | 4.8% | ||
| Q2 24 | 4.2% | 1.6% | ||
| Q1 24 | 1.4% | -1.2% |
| Q4 25 | 0.3% | 1.0% | ||
| Q3 25 | 0.3% | 0.9% | ||
| Q2 25 | 0.2% | 1.7% | ||
| Q1 25 | 0.5% | 1.3% | ||
| Q4 24 | 0.4% | 1.1% | ||
| Q3 24 | 0.5% | 1.1% | ||
| Q2 24 | 0.6% | 1.2% | ||
| Q1 24 | 0.1% | 1.4% |
| Q4 25 | -0.44× | — | ||
| Q3 25 | 26.69× | — | ||
| Q2 25 | 9.65× | -0.70× | ||
| Q1 25 | 2.48× | 0.14× | ||
| Q4 24 | — | 2.00× | ||
| Q3 24 | 2.11× | 0.86× | ||
| Q2 24 | 1.21× | 0.81× | ||
| Q1 24 | 0.40× | 0.06× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
VAC
| Cost Reimbursement | $467.0M | 38% |
| Time Share | $381.0M | 31% |
| Management And Exchange | $212.0M | 17% |
| Ancillary Revenues | $64.0M | 5% |
| Management Service | $55.0M | 4% |
| Service Other | $36.0M | 3% |
